Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 23998864)

1.

Hypertensive crisis in a patient with thyroid cancer.

Asha HS, Seshadri MS, Rajaratnam S.

Natl Med J India. 2012 Nov-Dec;25(6):339-40.

PMID:
23998864
2.
3.

Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma.

Pomares FJ, Cañas R, Rodriguez JM, Hernandez AM, Parrilla P, Tebar FJ.

Clin Endocrinol (Oxf). 1998 Feb;48(2):195-200.

PMID:
9579232
4.
5.

Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.

Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW.

Clin Endocrinol (Oxf). 2005 Dec;63(6):676-82.

PMID:
16343103
6.

Multiple endocrine neoplasia type 2.

Gertner ME, Kebebew E.

Curr Treat Options Oncol. 2004 Aug;5(4):315-25. Review.

PMID:
15233908
7.

Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess.

Kim J, Reutrakul S, Davis DB, Kaplan EL, Refetoff S.

Eur J Endocrinol. 2004 Dec;151(6):771-7.

8.
9.

Presentation of a medullary endocrine neoplasia 2A kindred with Cushing's syndrome.

Zaydfudim V, Stover DG, Caro SW, Phay JE.

Am Surg. 2008 Jul;74(7):659-61.

PMID:
18646485
10.

Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.

Sanso GE, Domene HM, Garcia R, Pusiol E, de M, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M.

Cancer. 2002 Jan 15;94(2):323-30.

12.

Pheochromocytoma and medullary thyroid carcinoma in a pregnant multiple endocrine neoplasia-2A patient.

Sarathi V, Bandgar TR, Menon PS, Shah NS.

Gynecol Endocrinol. 2011 Aug;27(8):533-5. doi: 10.3109/09513590.2010.507285. Epub 2010 Jul 30.

PMID:
20672905
13.

Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report.

Yamashita T, Lihara M, Okamoto J, Kanbe M, Ito Y, Kawakami M, Egawa S, Yamaguchi K, Obara T.

Jpn J Clin Oncol. 1997 Feb;27(1):42-5.

14.

[Multiple endocrine neoplasia syndrome type 2].

Khom'iak VV, Pavlovs'kyĭ MP, Boĭko NI, Dovgan' IuP, Gavrysh IaI, Kemin' RV.

Klin Khir. 2012 Aug;(8):55-7. Ukrainian.

PMID:
23113424
15.

[Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].

Sansó G, Domené HM, Iorcansky S, Barontini M.

Medicina (B Aires). 1998;58(2):179-84. Spanish.

PMID:
9706252
16.

[Multiple endocrine neoplasia type 2A].

Juodele L, Krasauskas V, Zindzius A, Juozaityte E, Pundzius J.

Medicina (Kaunas). 2006;42(3):215-24. Lithuanian.

18.

Patients with RET D631Y mutations most commonly present with pheochromocytoma and not medullary thyroid carcinoma.

Elston MS, Meyer-Rochow GY, Holdaway I, Conaglen JV.

Horm Metab Res. 2012 May;44(5):339-42. doi: 10.1055/s-0031-1295497. Epub 2012 Jan 24.

PMID:
22274720
19.

RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China.

Qi XP, Chen XL, Ma JM, Du ZF, Fei J, Yang CP, Cheng J, Song QZ, Han JS, Jin HY, Chen ZG, Wang JQ, Yang YP, Ying RB, Liu WT, Zhao Y, Chen CY, Jiang HL, Ke HP, Zhang XN.

Thyroid. 2012 Dec;22(12):1257-65. doi: 10.1089/thy.2012.0134.

PMID:
23210566
20.

[Multiple endocrine neoplasia syndromes. Type 2].

Juodele L, Juozaityte E, Zindzius A, Pundzius J.

Medicina (Kaunas). 2005;41(4):281-94. Review. Lithuanian.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk